Results 211 to 220 of about 86,826 (247)
Some of the next articles are maybe not open access.

Tumor Lysis Syndrome

Clinical Journal of Oncology Nursing, 2004
Tumor lysis syndrome (TLS) is an oncologic emergency characterized by electrolyte and metabolic disturbances that most commonly are associated with lymphoproliferative malignancies and chemotherapy administration. It is manifested by hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia.
Diane Cope, Jeannine M. Brant
openaire   +4 more sources

Tumor Lysis Syndrome

The Indian Journal of Pediatrics, 2012
Tumor lysis syndrome (TLS) refers to the constellation of deranged metabolic state, characterized by hyperkalemia, hyperphosphatemia, hyperuricemia, hypocalcemia, and/or azotemia, secondary to rapid breakdown of tumor cells. It is a life threatening emergency that typically follows administration of chemotherapy or may be spontaneous.
Aruna, Rajendran   +3 more
openaire   +3 more sources

Tumor Lysis Syndrome

Critical Care Nurse, 2022
Background Tumor lysis syndrome is a life-threatening oncologic emergency in adult and pediatric patients with hematologic cancer. It occurs most often in malignancies with rapid cell turnover and large tumor burden, but its incidence has risen in solid tumors.
openaire   +2 more sources

Tumor Lysis Syndrome in Solid Tumors

Supportive Cancer Therapy, 2005
Tumor lysis syndrome (TLS) consists of acute hyperuricemic nephropathy, hyperphosphatemia, hypocalcemia, hyperkalemia, and increased serum creatinine. It can be part of the disease presentation, especially in aggressive hematologic malignancies, or a part of the chemotherapy response. There are relatively few reports of TLS in solid tumors.
Frank E, Mott   +3 more
openaire   +2 more sources

Tumor lysis syndrome in elderly

Critical Reviews in Oncology/Hematology, 2007
The majority of cancers occur in adults over the age of 65, with about 70% of all cancer deaths in this population. Tumor lysis syndrome (TLS) is a complication of hematological and others malignancies, caused by massive tumor cell lysis due to chemotherapy, immunotherapy, radiotherapy.
PUMO V, SCIACCA D, MALAGUARNERA, Mariano
openaire   +3 more sources

Tumor lysis syndrome

Seminars in Hematology, 2001
Tumor lysis syndrome (TLS) is a constellation of metabolic disturbances observed in tumors with high cell turnover. It is associated with significant morbidity and mortality. TLS is characterized by the increased release of intracellular contents (uric acid, potassium, phosphorus) into the extracellular compartment, which can overwhelm the body's ...
openaire   +2 more sources

Tumor lysis syndrome

Seminars in Oncology Nursing, 1999
To review the pathophysiology, clinical manifestations, and management of tumor lysis syndrome.Published articles, case reports, and book chapters on tumor lysis syndrome.Tumor lysis syndrome is a very serious and sometimes life-threatening complication of cancer treatment. Identification of patients at risk and initiation of preventative interventions
openaire   +2 more sources

Acute tumor lysis syndrome

Seminars in Oncology, 2001
Abstract The electrolyte abnormalities and metabolic derangements associated with ATLS are a serious consequence in patients with both hematologic malignancies and solid tumors. While concern is primarily for those with highly proliferative hematopoietic disorders following treatment with exquisitely responsive chemotherapy, the practitioner should ...
openaire   +2 more sources

Incidence and Pathogenesis of Tumor Lysis Syndrome

2004
Tumor lysis syndrome (TLS) is a constellation of metabolic disturbances that may be observed in patients with malignancies. Clinically significant TLS can occur spontaneously, but most often is seen 48-72 h after initiation of cancer treatment.
LOCATELLI F, ROSSI, Francesca
openaire   +4 more sources

Overview of tumor lysis syndrome

Seminars in Oncology Nursing, 2002
To provide a general overview of tumor lysis syndrome (TLS) focusing on the incidence, epidemiology, and patient outcomes associated with the syndrome; review the role of the oncology nurse in impacting patient outcomes and identify evolving issues relating to TLS.Primary and tertiary literature related to TLS and clinical practice experience.Issues ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy